Ben Harrison is an analytic cancer scientist at HiberCell who works with assay design, imaging and supporting clinical trial research.
Prior to joining HiberCell, Ben was a research scientist at Biothera Pharmaceuticals, where he was responsible for biomarker and clinical assay development. He has spent 15 years in both the research and clinically regulated environments working to improve patient outcomes.
Ben earned his B.S. in microbiology at Michigan Technological University, and his M.S. in molecular biology at Oregon State University.